loadpatents
Patent applications and USPTO patent grants for Byers; Stephen W..The latest application filed is for "treating melanoma with mebendazole and a mitogen-activated kinase inhibitor".
Patent | Date |
---|---|
Treating melanoma with mebendazole and a mitogen-activated kinase inhibitor Grant 11,179,395 - Dakshanamurthy , et al. November 23, 2 | 2021-11-23 |
Predicting drug-target interactions and uses for drug repositioning and repurposing Grant 10,916,331 - Dakshanamurthy , et al. February 9, 2 | 2021-02-09 |
Treating Melanoma With Mebendazole And A Mitogen-activated Kinase Inhibitor App 20180263987 - Dakshanamurthy; Sivanesan ;   et al. | 2018-09-20 |
Predicting Drug-target Interactions And Uses For Drug Repositioning And Repurposing App 20180157786 - Dakshanamurthy; Sivanesan ;   et al. | 2018-06-07 |
Cadherin-11 inhibitors and methods of use thereof Grant 9,889,131 - Byers , et al. February 13, 2 | 2018-02-13 |
Cadherin-11 Inhibitors and Methods of Use Thereof App 20160151363 - Byers; Stephen W. ;   et al. | 2016-06-02 |
Substituted pyrazines as cadherin-11 inhibitors Grant 9,284,368 - Byers , et al. March 15, 2 | 2016-03-15 |
Small molecule inhibitors of AGBL2 Grant 9,199,918 - Byers , et al. December 1, 2 | 2015-12-01 |
Method For Predicting Drug-target Interactions And Uses For Drug Repositioning App 20150324546 - Dakshanamurthy; Sivanesan ;   et al. | 2015-11-12 |
Cadherin-11 Inhibitors and Methods of Use Thereof App 20150064168 - Byers; Stephen W. ;   et al. | 2015-03-05 |
Cadherin-11 inhibitors and methods of use thereof Grant 8,802,687 - Byers , et al. August 12, 2 | 2014-08-12 |
Small Molecule Inhibitors Of Agbl2 App 20130331328 - Byers; Stephen W. ;   et al. | 2013-12-12 |
Cadherin-11 Inhibitors And Methods Of Use Thereof App 20120128693 - Byers; Stephen W. ;   et al. | 2012-05-24 |
NCAGE Code | 4K6W1 | BYERS STEPHEN W |
CAGE Code | 4K6W1 | BYERS, STEPHEN W |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.